Transactivation of EGFR by LPS induces COX-2 expression in enterocytes

Steven J. McElroy, Stuart Hobbs, Michael Kallen, Noemi Tejera, Michael J. Rosen, Anatoly Grishin, Poojitha Matta, Claus Schneider, Jeffrey Upperman, Henri Ford, D. Brent Polk, Jörn Hendrik Weitkamp

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Necrotizing enterocolitis (NEC) is the leading cause of gastrointestinal morbidity and mortality in preterm infants. NEC is characterized by an exaggerated inflammatory response to bacterial flora leading to bowel necrosis. Bacterial lipopolysaccharide (LPS) mediates inflammation through TLR4 activation and is a key molecule in the pathogenesis of NEC. However, LPS also induces cyclooxygenase-2 (COX-2), which promotes intestinal barrier restitution through stimulation of intestinal cell survival, proliferation, and migration. Epidermal growth factor receptor (EGFR) activation prevents experimental NEC and may play a critical role in LPS-stimulated COX-2 production. We hypothesized that EGFR is required for LPS induction of COX-2 expression. Our data show that inhibiting EGFR kinase activity blocks LPS-induced COX-2 expression in small intestinal epithelial cells. LPS induction of COX-2 requires Src-family kinase signaling while LPS transactivation of EGFR requires matrix metalloprotease (MMP) activity. EGFR tyrosine kinase inhibitors block LPS stimulation of mitogen-activated protein kinase ERK, suggesting an important role of the MAPK/ERK pathway in EGFR-mediated COX-2 expression. LPS stimulates proliferation of IEC-6 cells, but this stimulation is inhibited with either the EGFR kinase inhibitor AG1478, or the selective COX-2 inhibitor Celecoxib. Taken together, these data show that EGFR plays an important role in LPS-induction of COX-2 expression in enterocytes, which may be one mechanism for EGF in inhibition of NEC.

Original languageEnglish (US)
Article numbere38373
JournalPLoS One
Volume7
Issue number5
DOIs
StatePublished - May 31 2012
Externally publishedYes

Fingerprint

Enterocytes
enterocytes
prostaglandin synthase
transcriptional activation
Cyclooxygenase 2
Epidermal Growth Factor Receptor
lipopolysaccharides
Transcriptional Activation
Lipopolysaccharides
enterocolitis
Necrotizing Enterocolitis
mitogen-activated protein kinase
Celecoxib
phosphotransferases (kinases)
inflammation
Chemical activation
epidermal growth factor receptors
src-Family Kinases
MAP Kinase Signaling System
Cyclooxygenase 2 Inhibitors

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

McElroy, S. J., Hobbs, S., Kallen, M., Tejera, N., Rosen, M. J., Grishin, A., ... Weitkamp, J. H. (2012). Transactivation of EGFR by LPS induces COX-2 expression in enterocytes. PLoS One, 7(5), [e38373]. https://doi.org/10.1371/journal.pone.0038373

Transactivation of EGFR by LPS induces COX-2 expression in enterocytes. / McElroy, Steven J.; Hobbs, Stuart; Kallen, Michael; Tejera, Noemi; Rosen, Michael J.; Grishin, Anatoly; Matta, Poojitha; Schneider, Claus; Upperman, Jeffrey; Ford, Henri; Polk, D. Brent; Weitkamp, Jörn Hendrik.

In: PLoS One, Vol. 7, No. 5, e38373, 31.05.2012.

Research output: Contribution to journalArticle

McElroy, SJ, Hobbs, S, Kallen, M, Tejera, N, Rosen, MJ, Grishin, A, Matta, P, Schneider, C, Upperman, J, Ford, H, Polk, DB & Weitkamp, JH 2012, 'Transactivation of EGFR by LPS induces COX-2 expression in enterocytes', PLoS One, vol. 7, no. 5, e38373. https://doi.org/10.1371/journal.pone.0038373
McElroy SJ, Hobbs S, Kallen M, Tejera N, Rosen MJ, Grishin A et al. Transactivation of EGFR by LPS induces COX-2 expression in enterocytes. PLoS One. 2012 May 31;7(5). e38373. https://doi.org/10.1371/journal.pone.0038373
McElroy, Steven J. ; Hobbs, Stuart ; Kallen, Michael ; Tejera, Noemi ; Rosen, Michael J. ; Grishin, Anatoly ; Matta, Poojitha ; Schneider, Claus ; Upperman, Jeffrey ; Ford, Henri ; Polk, D. Brent ; Weitkamp, Jörn Hendrik. / Transactivation of EGFR by LPS induces COX-2 expression in enterocytes. In: PLoS One. 2012 ; Vol. 7, No. 5.
@article{037f556f9a9c453a94acc2e3aa086946,
title = "Transactivation of EGFR by LPS induces COX-2 expression in enterocytes",
abstract = "Necrotizing enterocolitis (NEC) is the leading cause of gastrointestinal morbidity and mortality in preterm infants. NEC is characterized by an exaggerated inflammatory response to bacterial flora leading to bowel necrosis. Bacterial lipopolysaccharide (LPS) mediates inflammation through TLR4 activation and is a key molecule in the pathogenesis of NEC. However, LPS also induces cyclooxygenase-2 (COX-2), which promotes intestinal barrier restitution through stimulation of intestinal cell survival, proliferation, and migration. Epidermal growth factor receptor (EGFR) activation prevents experimental NEC and may play a critical role in LPS-stimulated COX-2 production. We hypothesized that EGFR is required for LPS induction of COX-2 expression. Our data show that inhibiting EGFR kinase activity blocks LPS-induced COX-2 expression in small intestinal epithelial cells. LPS induction of COX-2 requires Src-family kinase signaling while LPS transactivation of EGFR requires matrix metalloprotease (MMP) activity. EGFR tyrosine kinase inhibitors block LPS stimulation of mitogen-activated protein kinase ERK, suggesting an important role of the MAPK/ERK pathway in EGFR-mediated COX-2 expression. LPS stimulates proliferation of IEC-6 cells, but this stimulation is inhibited with either the EGFR kinase inhibitor AG1478, or the selective COX-2 inhibitor Celecoxib. Taken together, these data show that EGFR plays an important role in LPS-induction of COX-2 expression in enterocytes, which may be one mechanism for EGF in inhibition of NEC.",
author = "McElroy, {Steven J.} and Stuart Hobbs and Michael Kallen and Noemi Tejera and Rosen, {Michael J.} and Anatoly Grishin and Poojitha Matta and Claus Schneider and Jeffrey Upperman and Henri Ford and Polk, {D. Brent} and Weitkamp, {J{\"o}rn Hendrik}",
year = "2012",
month = "5",
day = "31",
doi = "10.1371/journal.pone.0038373",
language = "English (US)",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - Transactivation of EGFR by LPS induces COX-2 expression in enterocytes

AU - McElroy, Steven J.

AU - Hobbs, Stuart

AU - Kallen, Michael

AU - Tejera, Noemi

AU - Rosen, Michael J.

AU - Grishin, Anatoly

AU - Matta, Poojitha

AU - Schneider, Claus

AU - Upperman, Jeffrey

AU - Ford, Henri

AU - Polk, D. Brent

AU - Weitkamp, Jörn Hendrik

PY - 2012/5/31

Y1 - 2012/5/31

N2 - Necrotizing enterocolitis (NEC) is the leading cause of gastrointestinal morbidity and mortality in preterm infants. NEC is characterized by an exaggerated inflammatory response to bacterial flora leading to bowel necrosis. Bacterial lipopolysaccharide (LPS) mediates inflammation through TLR4 activation and is a key molecule in the pathogenesis of NEC. However, LPS also induces cyclooxygenase-2 (COX-2), which promotes intestinal barrier restitution through stimulation of intestinal cell survival, proliferation, and migration. Epidermal growth factor receptor (EGFR) activation prevents experimental NEC and may play a critical role in LPS-stimulated COX-2 production. We hypothesized that EGFR is required for LPS induction of COX-2 expression. Our data show that inhibiting EGFR kinase activity blocks LPS-induced COX-2 expression in small intestinal epithelial cells. LPS induction of COX-2 requires Src-family kinase signaling while LPS transactivation of EGFR requires matrix metalloprotease (MMP) activity. EGFR tyrosine kinase inhibitors block LPS stimulation of mitogen-activated protein kinase ERK, suggesting an important role of the MAPK/ERK pathway in EGFR-mediated COX-2 expression. LPS stimulates proliferation of IEC-6 cells, but this stimulation is inhibited with either the EGFR kinase inhibitor AG1478, or the selective COX-2 inhibitor Celecoxib. Taken together, these data show that EGFR plays an important role in LPS-induction of COX-2 expression in enterocytes, which may be one mechanism for EGF in inhibition of NEC.

AB - Necrotizing enterocolitis (NEC) is the leading cause of gastrointestinal morbidity and mortality in preterm infants. NEC is characterized by an exaggerated inflammatory response to bacterial flora leading to bowel necrosis. Bacterial lipopolysaccharide (LPS) mediates inflammation through TLR4 activation and is a key molecule in the pathogenesis of NEC. However, LPS also induces cyclooxygenase-2 (COX-2), which promotes intestinal barrier restitution through stimulation of intestinal cell survival, proliferation, and migration. Epidermal growth factor receptor (EGFR) activation prevents experimental NEC and may play a critical role in LPS-stimulated COX-2 production. We hypothesized that EGFR is required for LPS induction of COX-2 expression. Our data show that inhibiting EGFR kinase activity blocks LPS-induced COX-2 expression in small intestinal epithelial cells. LPS induction of COX-2 requires Src-family kinase signaling while LPS transactivation of EGFR requires matrix metalloprotease (MMP) activity. EGFR tyrosine kinase inhibitors block LPS stimulation of mitogen-activated protein kinase ERK, suggesting an important role of the MAPK/ERK pathway in EGFR-mediated COX-2 expression. LPS stimulates proliferation of IEC-6 cells, but this stimulation is inhibited with either the EGFR kinase inhibitor AG1478, or the selective COX-2 inhibitor Celecoxib. Taken together, these data show that EGFR plays an important role in LPS-induction of COX-2 expression in enterocytes, which may be one mechanism for EGF in inhibition of NEC.

UR - http://www.scopus.com/inward/record.url?scp=84861663311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861663311&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0038373

DO - 10.1371/journal.pone.0038373

M3 - Article

C2 - 22675459

AN - SCOPUS:84861663311

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 5

M1 - e38373

ER -